Renalytix AI plc Made Headway

Thu, Feb 29, 2024 at 07:10 PM

Renalytix AI plc (RNLX:NASDAQ) shot up at $1.17, a gain of 41%. On Thu, Feb 29, 2024, RNLX:NASDAQ hit a New 2-Week High of $1.17. The stock appeared on our News Catalysts scanner on Thu, Feb 15, 2024 at 09:40 AM in the 'EARNINGS' category. From Thu, Feb 15, 2024, the stock recorded 66.67% Up Days and 50.00% Green Days

The stock spiked on Mon, Feb 12, 2024 at $2.4 with a volume of 52M+.

About Renalytix AI plc (RNLX:NASDAQ)

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally.

Top 10 Gainers:

Societal CDMO Inc. (SCTL:NASDAQ), 132.61%
Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
Enveric Biosciences Inc. (ENVB:NASDAQ), 74.7%
Sidus Space Inc. (SIDU:NASDAQ), 61.22%
Ideanomics, Inc. (IDEX:NASDAQ), 54.9%
LAVA Therapeutics N.V. (LVTX:NASDAQ), 54.17%
Eastman Kodak Company (KODK:NYSE), 52.57%
OneMedNet Corp. (ONMD:NASDAQ), 45.82%
Renalytix AI plc (RNLX:NASDAQ), 40.98%
Laser Photonics Corporation (LASE:NASDAQ), 39.42%